Editorial Board — Medscape Ophthalmology
Board Members
- David M. Brown, MD
- The Methodist Hospital
Weill Cornell College of Medicine
Cornell University-Houston
Greater Houston Retina Research & Retina Consultants
Houston, Texas
- The Methodist Hospital
- David K. Coats, MD
- Baylor College of Medicine
Texas Children's Hospital
Houston, Texas
- Baylor College of Medicine
- C. Stephen Foster, MD
- Harvard Medical School
Boston, Massachusetts
Massachusetts Eye Research and Surgery Institute
Cambridge, Massachusetts
- Harvard Medical School
- Dorothy N. Friedberg, MD, PhD
- New York University School of Medicine
New York University Langone Medical Center
New York, NY
- New York University School of Medicine
- Ivan Goldberg, MBBS
- University of Sydney
Sydney Eye Hospital
Sydney, New South Wales, Australia
- University of Sydney
- L. Jay Katz, MD
- Jefferson Medical Hospital
Wills Eye Institute
Philadelphia, Pennsylvania
- Jefferson Medical Hospital
- Herbert E. Kaufman, MD
- Louisiana State University Medical School
New Orleans, Louisiana
- Louisiana State University Medical School
- James E. McDonald, II, MD
- University of Arkansas Medical Center
Little Rock, Arkansas
McDonald Eye Associates
Fayetteville, Arkansas
- University of Arkansas Medical Center
- F. Hampton Roy, MD
- University of Arkansas
Hampton Roy Eyecare
Little Rock, Arkansas
- University of Arkansas
- Roger F. Steinert, MD
- University of California Irvine
Irvine, California
University of California Irvine Medical Center
Orange, California
- University of California Irvine
Board Member Details
David M. Brown, MD
Clinical Associate Professor, The Methodist Hospital, Weill Cornell College of Medicine, Cornell University-Houston; Director of Clinical Research, Greater Houston Retina Research & Retina Consultants of Houston, Houston, Texas
David M. Brown, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Alcon Laboratories, Inc.; Alimera Sciences; Allergan, Inc.; Eli Lilly and Company; Genentech, Inc.; Molecular Partners AG; Novartis Pharmaceuticals Corporation; Ophthotech Corporation; Paloma Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; Schering-Plough Corporation; Sirion Therapeutics; ThromboGenics, Inc.
Served as a speaker or a member of a speakers bureau for: Genentech, Inc.
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Alcon Laboratories, Inc.; Allergan, Inc.; Carl Zeiss, Inc.; Genentech, Inc.; Heidelberg Pharma AG; Molecular Partners AG; Novartis Pharmaceuticals Corporation; Paloma Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; STEBA Laboratories Ltd.; ThromboGenics, Inc.
Received income in an amount equal to or greater than $250 from: Alcon Laboratories, Inc.; Allergan, Inc.; Genentech, Inc.; Heidelberg Pharma AG; Molecular Partners AG; Novartis Pharmaceuticals Corporation; Paloma Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; ThromboGenics, Inc.
David K. Coats, MD
Professor of Ophthalmology and Pediatrics, Baylor College of Medicine; Chief of Ophthalmology, Texas Children's Hospital, Houston, Texas
David K. Coats, MD, has disclosed no relevant financial relationships.
C. Stephen Foster, MD
Professor, Department of Ophthalmology, Harvard Medical School; Founder and President, Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts
C. Stephen Foster, MD, has disclosed no relevant financial relationships.
Dorothy N. Friedberg, MD, PhD
Clinical Professor of Ophthalmology, New York University School of Medicine; Staff Physician, Department of Ophthalmology, New York University Langone Medical Center, New York, New York
Dorothy N. Friedberg, MD, PhD, has disclosed no relevant financial relationships.
Ivan Goldberg, MBBS
Clinical Associate Professor, University of Sydney; Head, Glaucoma Unit, Sydney Eye Hospital, Sydney, New South Wales, Australia
Ivan Goldberg, MBBS, has disclosed the following relevant financial relationships:
Served as director, officer, partner, employee, advisor, consultant, or trustee for: Alcon Laboratories, Inc.; Allergan, Inc.; Merck & Co., Inc.; Pfizer Inc
Served as a speaker or member of a speakers bureau for: Alcon Laboratories, Inc.; Allergan, Inc.
L. Jay Katz, MD
Professor, Jefferson Medical College; Director of Glaucoma Service, Wills Eye Institute, Philadelphia, Pennsylvania
L. Jay Katz, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Allergan, Inc.; Lumenis
Served as a speaker or member of a speakers bureau for: Alcon Laboratories, Inc.; Allergan, Inc.; Lumenis; Merck & Co., Inc.
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Alcon Laboratories, Inc.; Allergan, Inc.; Glaukos
Herbert E. Kaufman, MD
Professor of Ophthalmology, Pharmacology, and Microbiology, Louisiana State University Medical School, New Orleans, Louisiana
Herbert E. Kaufman, MD, has disclosed the following relevant financial relationships:
Served as director, officer, partner, employee, advisor, consultant, or trustee for: Bausch & Lomb Inc.; Rapid Pathogen Screening
James E. McDonald, II, MD
Assistant Clinical Professor, Department of Ophthalmology, University of Arkansas Medical Center, Little Rock, Arkansas; Medical and Surgical Director, McDonald Eye Associates, Fayetteville, Arkansas
James E. McDonald, II, MD, has disclosed the following relevant financial relationships:
Served as a consultant for: Bausch & Lomb Inc.; Hoya Vision Care North America; Inspire Pharmaceuticals; STAAR Surgical Company; TearScience, Inc.; WaveTec Vision
Received income in an amount equal to or greater than $250 from: Bausch & Lomb Inc.; Hoya Vision Care North America; Inspire Pharmaceuticals; STAAR Surgical Company; TearScience, Inc.; WaveTec Vision
F. Hampton Roy, MD
Associate Professor of Ophthalmology, University of Arkansas; Ophthalmologist, Hampton Roy Eyecare, Little Rock, Arkansas
F. Hampton Roy, MD, has disclosed no relevant financial relationships.
Roger F. Steinert, MD
Irving H. Leopold Professor and Chair of Ophthalmology, Professor of Biomedical Engineering; Director, Gavin Herbert Eye Institute, University of California Irvine, Irvine, California; Chief, Department of Ophthalmology, University of California Irvine Medical Center, Orange, California
Roger F. Steinert, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Abbott Medical Optics; LenSx; OptiMedica; ReVision Optics